Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Research UK
National Cancer Institute (NCI)
Cancer Research UK
Inhibrx Biosciences, Inc